HHS orders more monkeypox vaccine
The Department of Health and Human Services July 1 ordered an additional 2.5 million doses of Bavarian Nordic's JYNNEOS, an FDA-licensed vaccine for prevention of smallpox and monkeypox, for use in responding to current or future monkeypox outbreaks and as part of the nation’s smallpox preparedness. Deliveries from this latest order will begin arriving at the Strategic National Stockpile later this year and will continue through early 2023.
This order brings the total vaccine doses to be delivered in 2022 and 2023 to more than 4 million. As of July 1, the CDC has reported approximately 460 U.S. cases of monkeypox.
Related News Articles
Headline
President Trump signed an executive order May 29 that directs the Centers for Disease Control and Prevention and the Advisory Committee on Immunization…
Headline
The Centers for Disease Control and Prevention today released a report highlighting data on patients hospitalized during a 2025 measles outbreak centered in…
Headline
The Centers for Disease Control and Prevention released a Health Alert Network Health Update May 18 informing clinicians about testing available for patients…
Headline
An outbreak of measles in Utah has grown to 663 cases, the state’s Department of Health and Human Resources reported May 12. There have been 466 cases…
Headline
A Centers for Disease Control and Prevention report released May 14 found that U.S.-reported dengue cases in 2024 increased 359% above the annual average from…
Headline
The Centers for Disease Control and Prevention announced May 14 that 41 people across the U.S. are being monitored for symptoms of hantavirus following an…